Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Der Nervenarzt|September 28, 2012
[Experimental therapy approaches for ischemic stroke]C Kleinschnitz, N PlesnilaEnvironmental Health Perspectives|August 1, 1990
Retinoic acid induced differentiation and commitment in HL-60 cellsP A Meyer, C KleinschnitzHamostaseologie|August 4, 2010
The role of glycoprotein Ibalpha and von Willebrand factor interaction in stroke developmentG Stoll, C Kleinschnitz, B NieswandtDer Nervenarzt|May 6, 2022
[Gene-based treatment in spinal muscular atrophy]T Hagenacker, U Schara-Schmidt, C KleinschnitzDer Nervenarzt|February 7, 2018
[Coagulation factors and multiple sclerosis : Key factors in the pathogenesis?]K Göbel, C Kleinschnitz, S G MeuthBrain Research. Molecular Brain Research|May 17, 2005
Contralateral cytokine gene induction after peripheral nerve lesions: dependence on the mode of injury and NMDA receptor signalingC Kleinschnitz, J Brinkhoff, C Sommer, et al.Der Nervenarzt|September 9, 2011
[Acute ischemic stroke. New approaches to antithrombotic treatment]P Kraft, B Nieswandt, G Stoll, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|March 10, 2007
Immunotherapeutic approaches in MS: update on pathophysiology and emerging agents or strategies 2006C Kleinschnitz, S G Meuth, B C Kieseier, et al.Journal of Neurology|February 15, 2024
Risdiplam improves subjective swallowing quality in non-ambulatory adult patients with 5q-spinal muscular atrophy despite advanced motor impairmentS Brakemeier, J Lipka, M Schlag, et al.GMS Journal for Medical Education|March 4, 2021
Neurological examination course in an interactive webinar as a solution during a pandemic. An overview of the implementation, optimization as well as critical considerationsC Oster, I Farhood, S Klebe, et al.Pageof 4